ELV — Evaluation History
Elevance Health, Inc.Deterministic Evaluations last 3 months
1 records| Date | Strategy | Price | Decision | Conf | Tech | Macro | Sector | Earn | Regime | Rationale |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Mar 2026 | SectorRotationLLM | $0.00 | BUY | 78% | 0 | 0 | 0 | 0 | Neutral | [Healthcare] ELV has recently reclaimed its 200-day moving average after a multi-month base consolidation near the $450–$470 range, with volume expanding on recent up days suggesting early institutional accumulation. Catalyst: Q1 2026 earnings report (expected mid-April) could serve as a significant re-rating event if medical loss ratios continue to improve; additionally, any favorable CMS Medicare Advantage rate announcements for 2027 would act as a near-term positive surprise. |
AI Evaluations last 3 months
0 recordsNo AI evaluations in the last 3 months.